With all the recent changes in pharma and Pharmacogenomics, it certainly sounds like some new directions and perhaps new individuals to lead these efforts are in the works, great though that she was able to retire, the designed efforts of marketing and investments continue to be the 2 most unpredictable and fast moving targets out there when it comes to healthcare. BD
“After more than a decade at Merck, Wendy Yarno, is leaving. The announcement was made this morning in an e-mail to Merck employees, according to Pharmaceutical Executive.”
http://www.pharmalot.com/2008/07/mercks-chief-marketing-exec-retires-whos-next/
0 comments :
Post a Comment